IDEXX Laboratories, Inc. IDXX
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -0.19% | 6.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.19% | 6.64% | |||
| Cost of Revenue | 2.84% | 4.64% | |||
| Gross Profit | -1.90% | 7.80% | |||
| SG&A Expenses | 1.75% | -2.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.64% | 1.64% | |||
| Operating Income | -5.46% | 17.37% | |||
| Income Before Tax | -4.29% | 17.38% | |||
| Income Tax Expenses | 4.27% | 2.36% | |||
| Earnings from Continuing Operations | -6.28% | 21.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.28% | 21.54% | |||
| EBIT | -5.46% | 17.37% | |||
| EBITDA | -5.08% | 16.58% | |||
| EPS Basic | -6.13% | 22.60% | |||
| Normalized Basic EPS | -4.69% | 18.06% | |||
| EPS Diluted | -6.09% | 23.05% | |||
| Normalized Diluted EPS | -4.52% | 18.29% | |||
| Average Basic Shares Outstanding | -0.16% | -0.87% | |||
| Average Diluted Shares Outstanding | -0.33% | -1.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||